Aplicaciones biomédicas de las nanoparticulas magneticas

Los nanomateriales han adquirido recientemente un gran interés debido a la gran con el diagnóstico como con la terapia de enfermedades muy variadas. Dentro de los nanomateriales utilizados en biomedicina, concretamente las nanopartículas magnéticas (NPMs) muestran un interés especial por las como agente de contraste en imagen de resonancia magnética (RM) y por tanto ser de gran utilidad en el diagnóstico de diferentes patologías. Otra de las aplicaciones potenciales de las NPMs en biomedicina se encuentra en el ámbito de la terapia, por ejemplo, la destrucción de tumores mediante hipertermia al aprovecharse la capacidad que poseen las partículas para producir calor en respuesta a la aplicación de campos magnéticos externos.

Histoire de la restauration

Vols. 6-8 have imprint: Paris [etc.] Lecoffre fils et Cie, successeurs, 1868-72.

Polytechnisches journal /

Volume 190 ink stamped "Gewerbe-und Handels-Verein"

Anthropologie der naturvölker,

Vol. 6 has title: Anthropologie ... von dr. Theodor Waitz ... Mit benutzung der vorarbeiten des verfassers fortgesetzt von dr. Georg Gerland ...

Seasonal variations in surface metabolite composition of Fucus vesiculosus and Fucus serratus sampled at outer Kiel Fjord (August 2012 - July 2013)

The chemical composition of surface associated metabolites of two Fucus species (Fucus vesiculosus and Fucus serratus) was analysed by means of gas chromatography-mass spectrometry (GC-MS) to describe temporal patterns in chemical surface composition. Method: The two perennial brown macroalgae F. vesiculosus and F. serratus were sampled monthly at Bülk, outer Kiel Fjord, Germany (54°27'21 N / 10°11'57 E) over an entire year (August 2012 - July 2013). Per month and species six non-fertile Fucus individuals were collected from mixed stands at a depth of 0.5 m under mid water level. For surface extraction approx. 50 g of the upper 5-10 cm apical thalli tips were cut off per species. The surface extraction of Fucus was performed according to the protocol of de Nys and co-workers (1998) with minor modifications (see Rickert et al. 2015). GC/EI-MS measurements were performed with a Waters GCT premier (Waters, Manchester, UK) coupled to an Agilent 6890N GC equipped with a DB-5 ms 30 m column (0.25 mm internal diameter, 0.25 mM film thickness, Agilent, USA). The inlet temperature was maintained at 250°C and samples were injected in split 10 mode. He carrier gas flow was adjusted to 1 ml min-1. Alkanes were used for referencing of retention times. For further details (GC-MS sample preparation and analysis) see the related publication (Rickert et al. submitted to PLOS ONE).

Relationship between therapeutic changes in blood pressure and outcomes in acute stroke: a metaregression

Both low and high blood pressure (BP) during the acute phase of stroke are associated independently with a poor outcome. Several small clinical trials have involved the alteration of BP and this study assessed the relationship between change in BP and functional outcome. Randomised controlled trials of interventions that would be expected, on pharmacological grounds, to alter BP in patients within one week of the onset of acute ischaemic or haemorrhagic stroke were sought using electronic searches. Data were collected on BP and clinical outcome. The relationship between the difference in on-treatment BP and odds ratios (OR) for outcomes was assessed using meta-regression. Thirty-seven trials involving 9,008 patients were included. A ‘U’ or ‘J’ shaped relationship were found between on-treatment BP difference and early death, death at the end of 90 day follow up, and combined death or dependency at the end of follow up. Although outcomes were not significantly reduced at any level of change in BP, the lowest odds occurred at: early death (OR 0.87, 95% confidence interval, CI 0.54 to 1.23) - 8.1 mmHg; death at end of follow up (OR 0.96, 95% CI 0.31 to 1.65) - 14.4 mmHg; and combined death or dependency at end of follow up (OR 0.95, 95% CI 0.11 to 1.72) - 14.6 mmHg. Although large falls or increases in BP are associated with a worse outcome, modest reductions may reduce death, and combined death or dependency, although the confidence intervals are wide and compatible with overall benefit or hazard.

A (Side A)

Free standing steel sculpture with combined media inserts. 95½" x 72" x 6" Museum of Photographic Art, San Diego

A (Side B)

Free standing steel sculpture with combined media inserts. 95½" x 72" x 6" Museum of Photographic Art, San Diego

A (Detail - Top)

Free standing steel sculpture with combined media inserts. 95½" x 72" x 6" Museum of Photographic Art, San Diego Re-Made Version

A (Side 1)

Free standing steel sculpture with combined media inserts. 95½" x 72" x 6" Museum of Photographic Art, San Diego Re-Made Version

A (Detail)

Free standing steel sculpture with combined media inserts. 95½" x 72" x 6" Museum of Photographic Art, San Diego Re-Made Version

A Novel 0.72-6.2GHz Continuously-Tunable Delta Sigma Fractional-N Frequency Synthesizer

This paper presents a wideband Delta Sigma-based fractional-N synthesizer with three integrated quadrature VCOs for multiple-input multiple-output (MIMO) wireless communication applications. It continuously covers a wide range frequency from 0.72GHz to 6.2GHz that is suitable for multiple communication standards. The synthesizer is designed in 0.13-um RE CMOS process. The dual clock full differential multi-modulus divide (MMD) with low power consumption can operate over 9GHz under the worst condition. In the whole range frequency from 0.72GHz to 6.2GHz, the maximal tuning range of the QVCOs reaches 33.09% and their phase noise is -119d8/Hz similar to 124d8/Hz @1MHz. Its current is less than 12mA at a 1.2V voltage supply when it operates at the highest frequency of 6.2GHz.